2009 annual financial data

Celldex Therapeutics, Inc. 2009 Operating margin

Celldex Therapeutics, Inc. 2009 operating margin with verified reported values.

Direct answer

Operating margin was -216.43%.

Operating income was -32,854,000 USD and net income was -36,525,000 USD.
Operating cash flow was -29,869,000 USD.

Get free Celldex Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15,180,000 USD
Operating income
-32,854,000 USD
Net income
-36,525,000 USD
Operating cash flow
-29,869,000 USD